Cagrilintide/semaglutide
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Novo Nordisk · Phase 3 · Recruiting · Enrollment 2500
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Cagrisema - dose level 1 | n/r | n/r | n/r | n/r |
| Cagrisema - dose level 2 | n/r | n/r | n/r | n/r |
| Semaglutide | n/r | n/r | n/r | n/r |
Not shown
- Cagrisema - dose level 1: endpoint not reported
- Cagrisema - dose level 2: endpoint not reported
- Semaglutide: endpoint not reported